J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry, is excited to officially share the news of our acquisition by Evaluate, a distinguished member of the Norstella family.
London, UK and Boston, MA – 10th January 2024: Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry. The global pharmaceutical industry is undergoing a period of great chang.
Evaluate heralded J+D Forecasting’s specialized models supported by cloud-based management and analytical solutions as a complement to its own consensus forecasting and consulting capabilities.
Evaluate Ltd, a Norstella company, announced today the expansion of its Competitive Intelligence (CI) Practice that will harness data-driven research methods and deep therapy area expertise from across the Norstella suite of companies. Medical, clinical and commercial teams will be able to partner with the .
Mike Gallup, CEO of Norstella, Evaluate’s parent company said: “Key assumptions that have underpinned the pharmaceutical sector for so long – for example, the US market’s supreme profitability and reliance on big M&A to fuel growth – are being tested. “The far-reaching Inflation Reduction Act (IRA), combined with .